These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada. Righolt CH, Willows K, Kliewer EV, Mahmud SM. PLoS One; 2022; 17(4):e0267646. PubMed ID: 35472093 [Abstract] [Full Text] [Related]
23. Temporal Trends in the Incidence of Anogenital Warts: Impact of Human Papillomavirus Vaccination. Naleway AL, Crane B, Smith N, Francisco M, Weinmann S, Markowitz LE. Sex Transm Dis; 2020 Mar; 47(3):179-186. PubMed ID: 31880738 [Abstract] [Full Text] [Related]
26. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Blomberg M, Dehlendorff C, Munk C, Kjaer SK. Clin Infect Dis; 2013 Oct; 57(7):929-34. PubMed ID: 23804192 [Abstract] [Full Text] [Related]
27. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data. Ali H, McManus H, O'Connor CC, Callander D, Kong M, Graham S, Saulo D, Fairley CK, Regan DG, Grulich A, Low N, Guy RJ, Donovan B. Med J Aust; 2017 Mar 20; 206(5):204-209. PubMed ID: 28301790 [Abstract] [Full Text] [Related]
29. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Lévesque LE. Pediatrics; 2015 May 20; 135(5):e1131-40. PubMed ID: 25917991 [Abstract] [Full Text] [Related]
32. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, Young C, Netterlid E, Sparén P, Arnheim-Dahlström L. J Natl Cancer Inst; 2013 Apr 03; 105(7):469-74. PubMed ID: 23486550 [Abstract] [Full Text] [Related]
33. Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls. Blomberg M, Dehlendorff C, Sand C, Kjaer SK. Clin Infect Dis; 2015 Sep 01; 61(5):676-82. PubMed ID: 25944340 [Abstract] [Full Text] [Related]
34. Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18. Chow EPF, Carter A, Vickers T, Fairley CK, McNulty A, Guy RJ, Regan DG, Grulich AE, Callander D, Khawar L, Machalek DA, Donovan B. Lancet Infect Dis; 2021 Dec 01; 21(12):1747-1756. PubMed ID: 34339639 [Abstract] [Full Text] [Related]
35. [Age for HPV vaccination: recommandations from the French high council of public health]. Heard I, Floret D. Med Sci (Paris); 2013 Dec 01; 29(12):1161-6. PubMed ID: 24356148 [Abstract] [Full Text] [Related]
36. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented]. Kiellberg Larsen H, Kofoed K, Sand C. Ugeskr Laeger; 2013 Feb 04; 175(6):349-53. PubMed ID: 23402241 [Abstract] [Full Text] [Related]
38. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure. Lurie S, Mizrachi Y, Chodick G, Katz R, Schejter E. Gynecol Oncol; 2017 Aug 04; 146(2):299-304. PubMed ID: 28602548 [Abstract] [Full Text] [Related]
39. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Sex Transm Infect; 2009 Dec 04; 85(7):499-502. PubMed ID: 19837728 [Abstract] [Full Text] [Related]